fda bans bpc 157 FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the compounding list now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled the Item Volume::1 Fluid Ounce The Power of Peptides: IV Therapy / Injectables

fda bans bpc 157 FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the compounding list now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled the Item Volume::1 Fluid Ounce The Power of Peptides: IV Therapy / Injectables

The Power of Peptides: GLP-1/GIP, SLU-PP-332, and 5-Amino-1MQ Molecule Explained - YouTube

For gastrointestinal indications, systemic or oral administration is appropriate because the entire gut is the target

IV Therapy / Injectables

Item Volume::1 Fluid Ounce

Combination evaluation is thin, even though most people research stacks rather than singles